Publication: Prolonged therapy of hepatitis delta for 96 weeks with pegylated-interferon-α-2a plus tenofovir or placebo does not prevent hdv rna relapse after treatment: The hidit-2 study
No Thumbnail Available
Date
2014-04-01
Authors
Authors
Wedemeyer, H.
Yurdaydin, C.
Ernst, S.
Caruntu, F. A.
Curescu, M. G.
Yalcin, K.
Akarca, U. S.
Gürel, Selim
Zeuzem, S.
Erhardt, A.
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
Description
Bu çalışma, 09-13, Nisan 2014 tarihlerinde London[İngiltere]’de düzenlenen 49. Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver Kongresi‘nde bildiri olarak sunulmuştur.
Keywords
Science & technology, Life sciences & biomedicine, Gastroenterology & hepatology, Gastroenterology & hepatology